What's New in
|
The following articles are provided for
|
Katz Eye Institute is pleased to welcome Anil Vedula, M.D. and Aarup Kubal, M.D. to our practice.
The FDA has just approved an expanded range of high-power cylinder correction intraocular lens implants for those patients that have a cataract and astigmatism.
“Age-Related Macular Degenerative, AMD, is a leading cause of vision loss in Americans age 60 and older. It is a disease that causes cells in the macula- the part of the eye that allows us to see in fine detail – to die.
“For patients diagnosed with glaucoma, taking medications for the condition appears to improve survival, researchers found” according to Medpage Today.
Read Full Story
“Action packed video games like Halo and Call of Duty can enhance visual attention, the ability that allows us to focus on relevant visual information,” reports Science Daily. Dr. Daphne Bavelier et al from the U of Rochester reported their findings in this month’s WIREs Cognitive Science.
When patients with astigmatism undergoing cataract surgery received a TORIC INTRAOCULAR LENS implant they enjoyed very good distance vision after surgery without the need for glasses.
“Individuals who have higher blood glucose levels and poorer control of those levels over time (as measured by their HbA1c levels which is a measure of the blood glucose levels over time) appear more likely to develop eye-related complications (diabetic retinopathy) 10 years later” according to Science Daily.
Acupuncture was more effective in treating anisometropic amblyopia also known as “lazy eye” in children when compared to the standard treatment of wearing an eye patch according to a study reported by Dr. Dennis Lam in the Archives of Ophthalmology.
Presbyopia starts after the age of forty. The lens in our eye begins to thicken and we lose the ability to see well at near: for example blurry vision when reading a book or a text message. Current treatments include bifocals or reading glasses, LASIK vision correction in one eye for near - mono-vision LASIK, and the replacement of the natural lens with a high technology lens such as the ReStor lens. However, more advanced treatments are coming our way as reported in Science Daily.
The visual portrayal of depression in the world of art has been through darkness;shades of grays and no bright colors. “Scientific findings now lend empirical support to this representation of depression that everything looks gray when you feel blue” reports Medical News Today.
A new technology called ultra short pulse laser or femtosecond laser will advance
cataract surgery to a new level – the first major advance since phacoemulsification
was developed 40 years ago.
Ocular Rosacea is a very common disorder characterized by eye irritation, dryness and blurred vision.
“Elderly people with visual disorders that are left untreated are significantly
more likely to develop Alzheimer’s disease”.
“Glaucoma patients who take medication for Glaucoma appear to have a reduced likelihood of death” according to a report in the Archives of Ophthalmology published in February 2010.
“There’s more to the eye makeup that gave Queen Nefertiti and other ancient
Egyptian royals those stupendous gazes and legendary beauty than meets
the eye,” reports Science Daily.
Read Full Story
Patients with moderate and advanced macular degeneration benefi ted from cataract surgery. This was reported by the American Academy of Ophthalmology.
Glaucoma, a disease of the eye caused by death of the nerve fibers, and is associated with increased pressure in the eye. The treatment for this disorder is primarily aimed at lowering that pressure.
In the month of August, important papers announced significant advances in the treatment of Macular Degeneration.
Using eye drops containing nerve growth factor restored some vision in patients with advanced glaucoma.
Implantable Collamer Lens (ICL) is a recent advancement in the correction of high myopia.
Light skinned people with many freckles and skin moles - (which develop when the skin is over exposed to ultraviolet (UV) light) - are at greater risk for developing melanomas of the skin.
Latisse is a drop recently approved by the FDA for increasing the growth of eyelashes. This treatment results in eyelashes that are 25% longer, 106% thicker and 18% darker than
before treatment.
Researchers in Oxford, England, reviewed data from 118 men with Diabetes. They also studied this group for evidence of Obstructive Sleep Apnea.
Cataracts can cause more than just loss of vision; they are also associated with a loss of cognitive function (the way a person processes information) and depressive mental status in elderly patients.
In ReStor Intraocular lens used in cataract surgery has allowed more than 90% of patients to see well distance and near without depending on glasses.
"New research shows that people with blue eyes have a single, common ancestor" according to research reported in Science Daily.
An experimental first step for treating the cause of macular degeneration was undertaken last week at the University of Florida when researchers injected a new anti-inflammatory drug into the eye of a patient with macular degeneration.
Gold, according to Eye World Magazine (Nov. '7), was used in the treatment of such medical disorders as measles, skin ulcers, and smallpox in the ancient cultures.
Glaucoma is one of the leading causes of preventable blindness in America. While glaucoma can be successfully treated it is best to detect it early.
"A revolutionary treatment for blindness in children" is undergoing the first clinical trial at the University College London. The study involves adults and children Leber's Congenital Amaurosis, a retinal condition which leads to blindness at a young age.
Researches have developed a model to identify patients at high risk of developing glaucoma.
Patients with probable Alzheimer's have an identifiable pattern of nerve fiber loss in their retinas. They also have an abnormal blood flow rate and narrowing of the column of blood in the retinal veins.
VISIT US AT: 1776 N. Pine Island Rd, Suite 214, Plantation, FL 33322
PH: 800-680-6182 | FAX: 954-452-9481
EMAIL US